CSTL
Castle Biosciences Inc
35.60$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.4% | 18.8% | 19.0% | 16.7% | 18.2% | 18.7% | 18.6% | 20.5% | 22.5% | 21.0% | 24.5% | 22.9% | 22.7% | |
| 81.6% | 81.2% | 81.0% | 83.3% | 81.8% | 81.3% | 81.4% | 79.5% | 77.5% | 79.0% | 75.5% | 77.1% | 77.3% | |
| 21.0% | 19.7% | 18.9% | 16.2% | 14.4% | 13.5% | 14.3% | 14.8% | 15.6% | 15.5% | 17.2% | 14.0% | 15.5% | |
| 26.2% | 25.9% | 24.6% | 21.2% | 24.1% | 22.7% | 24.8% | 26.6% | 27.8% | 26.8% | 28.5% | 24.3% | 26.7% | |
| 97.3% | 89.8% | 88.5% | 77.6% | 75.9% | 76.6% | 113.1% | 84.5% | 85.7% | 83.3% | 97.5% | 80.1% | 86.2% | |
| -15.7% | -8.6% | -7.5% | 5.8% | 5.9% | 4.7% | -31.7% | -4.9% | -8.2% | -4.4% | -22.0% | -3.0% | -9.0% | |
| 0.0% | 0.0% | 0.0% | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.2% | 0.1% | |
| -11.2% | -3.8% | -3.4% | 9.1% | 9.7% | 9.1% | -29.9% | -0.2% | -0.5% | -3.1% | -17.2% | -1.6% | -5.4% | |
| 0.1% | 0.1% | 0.1% | -1.2% | 7.0% | -2.0% | -0.5% | -5.4% | 0.1% | -0.4% | 0.1% | 0.4% | 0.1% | |
| -11.2% | -3.9% | -3.5% | 10.3% | 2.6% | 11.1% | -29.4% | 5.2% | -0.6% | -2.7% | -17.4% | -2.0% | -5.4% | |
| -6.0% | 1.0% | 1.2% | 13.2% | 14.0% | 15.9% | 4.0% | 3.8% | 4.2% | 1.2% | -12.4% | 2.5% | -0.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.